Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma Carol A. KruseDawn H. MitchellKevin O. Lillehei OriginalPaper Pages: 97 - 112
Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model Changnian LiuBruce F. KimlerRobert A. Morantz OriginalPaper Pages: 113 - 123
Intracranial ependymoma long term outcome, patterns of failure Jeffrey J. KovalicNicolaus FlarisKevin A. Roth OriginalPaper Pages: 125 - 131
Recurrent brainstem gliomas treated with oral VP-16 Marc C. Chamberlain OriginalPaper Pages: 133 - 139
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) Lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA Edward W. B. Jeffes IIIYancey B. BeamerGale A. Granger OriginalPaper Pages: 141 - 155
Neonatal medulloblastoma Takamasa KayamaTakashi YoshimotoYoshiharu Sakurai OriginalPaper Pages: 157 - 163
Brain metastases in breast cancer; natural history, prognostic factors and outcome W. BoogerdV. W. VosG. Baris OriginalPaper Pages: 165 - 174
Phase II study of tiazofurin in gliomas in adults David J. StewartElizabeth EisenhauerAdrian Langleben OriginalPaper Pages: 175 - 179
Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies Sarah A. TaylorJohn CrowleyJohn Wendall Goodwin OriginalPaper Pages: 181 - 184
Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors Yasuo IwadateHiroki NambaKanji Sueyoshi OriginalPaper Pages: 185 - 193